Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells

被引：0
|
作者：
Ami N. Shah
Justin M. Summy
Jing Zhang
Serk In Park
Nila U. Parikh
Gary E. Gallick
机构：
[1] University of Texas M.D. Anderson Cancer Center,Department of Surgical Oncology
[2] University of Texas M.D. Anderson Cancer Center,Department of Cancer Biology
来源：
Annals of Surgical Oncology | 2007年 / 14卷
关键词：
Pancreatic cancer; EMT; Gemcitabine chemoresistance; c-Met; Cancer stem cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3629 / 3637
页数：8
相关论文
共 50 条
  • [31] Establishment of Novel Gemcitabine-Resistant Mouse Pancreatic Cancer Cell Line
    Kadoi, Y.
    Shimizu, K.
    Nishimura, A.
    Takegaki, Y.
    Miyoshi, M.
    Akagi, T.
    Sasai, K.
    Hori, Y.
    PANCREAS, 2017, 46 (10) : 1408 - 1409
  • [32] Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer
    M Reni
    L Pasetto
    G Aprile
    S Cordio
    E Bonetto
    S Dell'oro
    P Passoni
    L Piemonti
    C Fugazza
    G Luppi
    C Milandri
    R Nicoletti
    A Zerbi
    G Balzano
    V Di Carlo
    A A Brandes
    British Journal of Cancer, 2006, 94 : 785 - 791
  • [33] Triptolide Cooperates With Cisplatin to Induce Apoptosis in Gemcitabine-Resistant Pancreatic Cancer
    Zhu, Wenbo
    Li, Jingjie
    Wu, Sihan
    Li, Shifeng
    Le, Liang
    Su, Xingwen
    Qiu, Pengxin
    Hu, Haiyan
    Yan, Guangmei
    PANCREAS, 2012, 41 (07) : 1029 - 1038
  • [34] Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
    Ru Chen
    Lisa A Lai
    Yumi Sullivan
    Melissa Wong
    Lei Wang
    Jonah Riddell
    Linda Jung
    Venu G. Pillarisetty
    Teresa A. Brentnall
    Sheng Pan
    Scientific Reports, 7
  • [35] Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
    Chen, Ru
    Lai, Lisa A.
    Sullivan, Yumi
    Wong, Melissa
    Wang, Lei
    Riddell, Jonah
    Jung, Linda
    Pillarisetty, Venu G.
    Brentnall, Teresa A.
    Pan, Sheng
    SCIENTIFIC REPORTS, 2017, 7
  • [36] Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells
    Zhao, Hengqiang
    Duan, Qingke
    Zhang, Zhengle
    Li, Hehe
    Wu, Heshui
    Shen, Qiang
    Wang, Chunyou
    Yin, Tao
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21 (09) : 2055 - 2067
  • [37] Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine-resistant pancreatic cancer cells
    Kim, Dong Joon
    Park, Young Soo
    Kang, Min Gu
    You, Yeon-Mi
    Jung, Yuri
    Koo, Han
    Kim, Jung-Ae
    Kim, Mi-Ju
    Hong, Seung-Mo
    Lee, Kyong Bun
    Jang, Ja-June
    Park, Kyung Chan
    Yeom, Young Ii
    EXPERIMENTAL CELL RESEARCH, 2015, 336 (01) : 119 - 129
  • [38] Identifying genes with differential expression in gemcitabine-resistant pancreatic cancer cells using comprehensive transcriptome analysis
    Nakai, Y
    Otsuka, M
    Hoshida, Y
    Tada, M
    Komatsu, Y
    Kawabe, T
    Omata, M
    ONCOLOGY REPORTS, 2005, 14 (05) : 1263 - 1267
  • [39] Antiproliferative Activity of Piceamycin by Regulating Alpha-Actinin-4 in Gemcitabine-Resistant Pancreatic Cancer Cells
    Lee, Jee-Hyung
    Choi, Jin Ho
    Lee, Kyung-Min
    Lee, Min Woo
    Ku, Ja-Lok
    Oh, Dong-Chan
    Shin, Yern-Hyerk
    Kim, Dae Hyun
    Cho, In Rae
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong -Tae
    Lee, Sang Hyub
    Lee, Sang Kook
    BIOMOLECULES & THERAPEUTICS, 2024, 32 (01) : 123 - 135
  • [40] A standardized extract of cultured Lentinula edodes mycelia downregulates cortactin in gemcitabine-resistant pancreatic cancer cells
    Islam, Shajedul
    Kitagawa, Takao
    Baron, Byron
    Kuhara, Keisuke
    Nagayasu, Hiroki
    Kobayashi, Masanobu
    Chiba, Itsuo
    Kuramitsu, Yasuhiro
    ONCOLOGY LETTERS, 2021, 22 (03)
12345